NASDAQ: OBLN Investor Notice: Update in Lawsuit Against Obalon Therapeutics Inc
An investor in Obalon Therapeutics Inc (NASDAQ: OBLN) filed a lawsuit against Obalon Therapeutics Inc (NASDAQ: OBLN) over alleged securities laws violations.
View full press release